FH and cancer: The authors found that the reductive glutamine-dependent pathway is the dominant mode in the metabolism of cancer cells (renal carcinoma) derived from patients with mutations in fumarate hydratase, as well as in cells with normal mitochondria subjected to acute pharmacological inhibition of ETC [61].